PATENT CLAIM ANALYSIS

Application Number: 16103350
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "217000"]

Abstract:
A methylphenidate, particularly including dextro-threo-methylphenidate, is administered to a subject to treat a speech, gait or limb impairment secondary to a genetically acquired pre-frontal cortex processing disease or disorder, particularly including multiple sclerosis, cerebral palsy, Angelman syndrome, Rett syndrome and Fragile-X syndrome.

Claim (Index 20):
The combination of  claim 1 , wherein (a) comprises THIP or an analog of THIP and the impairment further comprises non-specific hand wringing or arm flapping, and (b) comprises an MPH.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 96.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15596075', '15075375', '14793829', '14881516', '14970134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.88743818723787
- 35 USC 102 Novelty (BERT): 0.58390535135889
- Combined Prediction Score: 0.857084903649972
- Mean Citation Score: 666.170538
- Max Citation Score: 824.24695
- Similarity Product: 413.4987907328546

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test